Abstract:To assist drug development, many computational methods have been proposed to identify potential drug-disease treatment associations before wet experiments. Based on the assumption that similar drugs may treat similar diseases, most methods calculate the similarities of drugs and diseases by using various chemical or biological features. However, since these features may be unknown or hard to collect, such methods will not work in the face of incomplete data. Besides, due to the lack of validated negative samples in the drug-disease associations data, most methods have no choice but to simply select some unlabeled samples as negative ones, which may introduce noises and decrease the reliability of prediction. Herein, we propose a new method (TS-SVD) which only uses those known drug-protein, disease-protein and drug-disease interactions to predict the potential drug-disease associations. In a constructed drug-protein-disease heterogeneous network, assuming that drugs/diseases relating to some common proteins or diseases/drugs may be similar, we get the common neighbors count matrix of drugs/diseases, then convert it to a topological similarity matrix. After that, we get low dimensional embedding representations of drug-disease pairs by using topological features and singular value decomposition. Finally, a Random Forest classifier is trained to do the prediction. To train a more reasonable model, we select out some reliable negative samples based on the k -step neighbors relationships between drugs and diseases. Compared with some state-of-the-art methods, we use less information but achieve better or comparable performance. Meanwhile, our strategy for selecting reliable negative samples can improve the performances of these methods. Case studies have further shown the practicality of our method in discovering novel drug-disease associations.

Predicting Drug−disease Associations Via Sigmoid Kernel-Based Convolutional Neural Networks

Identification of Drug-Disease Associations Using Information of Molecular Structures and Clinical Symptoms Via Deep Convolutional Neural Network

Predicting Drug-Disease Associations Via Using Gaussian Interaction Profile and Kernel-Based Autoencoder

Prediction of drug–disease associations based on reinforcement symmetric metric learning and graph convolution network

A Highly Efficient Biomolecular Network Representation Model for Predicting Drug-Disease Associations.

A Model For Predicting Drug-Disease Associations Based On Dense Convolutional Attention Network

Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning

Predicting drug-disease associations by network embedding and biomedical data integration.

Drug–disease Associations Prediction Via Multiple Kernel-based Dual Graph Regularized Least Squares

In Silico Drug Repositioning Using Deep Learning and Comprehensive Similarity Measures

Graph-Based Neural Collaborative Filtering Model for Drug-Disease Associations Prediction

Prediction of Drug-Disease Associations Based on Multi-Kernel Deep Learning Method in Heterogeneous Graph Embedding

SAEROF: an ensemble approach for large-scale drug-disease association prediction by incorporating rotation forest and sparse autoencoder deep neural network

A Multi-graph Deep Learning Model for Predicting Drug-Disease Associations.

Predicting drug-disease associations through layer attention graph convolutional network

Prediction of Drug-Disease Associations and Their Effects by Signed Network-Based Nonnegative Matrix Factorization

Predicting drug-disease associations based on the known association bipartite network

Computational Approaches for Predicting Drug-Disease Associations: A Comprehensive Review

Drug-Disease Association Prediction Based on Neighborhood Information Aggregation in Neural Networks

Predicting drug-disease associations by using similarity constrained matrix factorization

Link Prediction Only with Interaction Data and Its Application on Drug Repositioning